Telecom CEO Warns Europe Faces Vulnerability to US Dominance in Satellites and AI Reddit Shares Slide Nearly 6 as Meta Launches Forum App for Facebook Groups Ouster Stock Surges on New Drone Interceptor Partnership Announcement SpaceX Eyes Nasdaq Listing as Starlink Drives Growth and Profitability Middle East Conflict Tests Gulf Regions Ambitions as an AI Hub Pfizer Prevails in Singapore Trademark Dispute with Merck Over Vaccine Brand Franklin Wireless Corp FKWL Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline MGRB Q1 2026 Earnings EPS Beats Estimates Bond Price Edges Higher on Steady Performance ADI Q1 2026 Earnings Strong EPS Beat Drives Stock Higher GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment eGain Corporation Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Phoenix Education Partners Inc PXED Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response USA Rare Earth Inc USAR Declines 37 as Support Levels Harden Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest Essential Properties Realty Trust EPRT Slips fractionally as Consolidation Continues Near Key Support Vera Therapeutics VERA Edges Higher as Stock Tests Resistance Zone Addex Therapeutics ADXN Slips 229 as Stock Hovers Near Key Support UK Exports to US Plunge 25 After Trumps Liberation Day Tariffs ESOA Q1 2026 Earnings EPS Surges Past Estimates with 743 Surprise HUHUTECH HUHU Plunges Over 16 as Selling Pressure Intensifies Key Support Levels in Focus PEW Q1 2026 Earnings EPS Surprise Beats Estimates by 505 Stock Falls 214 BHB Q1 2026 Earnings EPS Misses Estimates Shares Dip Slightly MSCI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Performance Medtronic MDT Q1 2026 Earnings Slight EPS Beat on Solid Operational Execution SolarEdge Technologies Inc SEDG Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Solar Market Ethan Allen Interiors Inc ETD Q1 2026 Earnings EPS Beats Estimates by 159 Stock Rises LCTX Q1 2026 Earnings EPS Misses Estimates as Company Advances Cell Therapy Pipeline